ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1588

Prevalence Of Oral Manifestations And Their Association With Clinical And Serological Profile In Systemic Sclerosis Patients- An Indian Study

Vijaya prasanna Parimi1, Tejaswini Ramineni2, Pradeep S Anand3, Vineeta Shobha4, Padmanabha Shenoy5, Geetabali Sircar6, kaushik Basu7, Anna C Das4, Geetha Amritrao Kale4, indranil sarkar8, Shinie Razil Goveas4, Biswarup Sengupta8, Caseena Kareem9, Yogananth Sakthivel4, Soma Halder Biswas7 and Neel Nallulwar8, 1ESIC Medical College and Super Specilaity Hospital, hyderabad, Telangana, India, 2Esic Medical College And Hospital, Sanathnagar, Hyderabad, Telangana, India, 3ESIC MEDICAL COLLEGE AND HOSPITAL, HYDERABAD, Telangana, India, 4St. John's Medical College Hospital, Bangalore, Bangalore, Karnataka, India, 5Shenoy's CARE, Kochi, Kerala, India, 6West Bengal Medical Education Service, Kolkata, West Bengal, India, 7Medical College, Kolkata, kolkata, West Bengal, India, 8IPGMER, Kolkata, kolkata, West Bengal, India, 9CARE, Kochi, kochi, Kerala, India

Meeting: ACR Convergence 2025

Keywords: Autoantibody(ies), Disability, physical function, risk assessment, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1553–1591) Systemic Sclerosis & Related Disorders – Clinical Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic sclerosis (SSC) is a chronic, multisystem autoimmune disease characterized by immune dysfunction, microangiopathy, and tissue remodelling. Orofacial manifestations, including xerostomia, microstomia, tooth decay, and periodontitis, affect up to 80% of SSC patients and significantly impact their quality of life. Despite their prevalence, these manifestations are often neglected compared to more life-threatening complications such as lung or kidney involvement. This study was designed to estimate the prevalence of oral-manifestations and to find their association with clinical and serological profiles in SSC patients.

Methods: A multi-centre study was conducted involving 131 SSC patients fulfilling ACR/EULAR-criteria. Comprehensive clinical-evaluation was performed including Modified-Rodnan-Skin-Score (MRSS) for skin tightness and Medsger’s-disease-severity-score for organ involvement. Oral-manifestations like presence of sicca symptoms, GERD were noted. Standardised-questionnaires like, Indian Cochin hand function Scale (ICHFS), Mouth Handicap in Systemic Sclerosis Scale (MHISS) were used to assess functional-impairment. Oro-facial health was evaluated using standardized dental indices such as Debri-Index(DI), Calculus-index(CI), number of missing-teeth, tooth-mobility, probing-depth(PD), gingival-bleeding(GB) and Clinical-attachment-level(CAL), Recession(REC) by a periodontist. Statistical-analysis was conducted using SPSS software V20, with statistical significance set at p < 0.05.

Results: Among 131 SSC patients, 45 were Limited Cutaneous SSC (LCSSC), 83 were Diffuse Cutaneous SSC (DCSSC) and 3 were sine scleroderma. The mean age was 42 years. Prevalence of oral manifestations like sicca symptoms was 59.5%, halitosis was 31.3%, Dysguesia was 36.6%, Reduced mouth opening was 63.4%, caries tooth was 60.3%%. Most of the oral manifestations were seen with a higher prevalence in DCSSC. Among the dental-examination findings, GB20,30,40, mean CAL, mean REC, DI and CI were higher in DSCC. The patients with early-disease ( < 5 years from first non-Raynauds symptom) constituted 43.5% and late-disease constituted 56.5%. All the oral-manifestations and dental-examination findings were higher in patients with late disease. The IC-HFS is higher in DCSSC patients with a mean score of 16.45 (p < 0.05) and among those with late disease with a mean score of 20.2(p < 0.05). Disease severity assessed by Medsger's score correlated positively with DCSSC, periodonditis, missing teeth, teeth mobility, GB, mean REC.

Conclusion: In this multicentre study, DCSSC exhibited significantly higher oral and dental manifestations with increased IC-HFS scores, GERD, reduced mouth opening, greater number of missing-teeth and periodontitis. Patients with late disease had more pronounced oral-manifestations and higher CAL, REC scores. These findings suggest that DCSSC and extended disease-duration are associated with more severe oral health complications, highlighting the importance of early dental intervention. Disease severity as assessed by Medsgers-score correlated-positively with presence of periodontitis indicating its possible role in disease pathogenesis.

Supporting image 1Prevalence Of Oral Manifestations In Systemic Sclerosis Patients

Supporting image 2Functional Measures Among Limited and Diffuse Cutaneous Systemic Sclerosis Patients

Supporting image 3Functional Measures Among Early and Late Systemic Sclerosis Patients


Disclosures: V. Parimi: None; T. Ramineni: None; P. Anand: None; V. Shobha: None; P. Shenoy: None; G. Sircar: None; k. Basu: None; A. Das: None; G. Kale: None; i. sarkar: None; S. Goveas: None; B. Sengupta: None; C. Kareem: None; Y. Sakthivel: None; S. Biswas: None; N. Nallulwar: None.

To cite this abstract in AMA style:

Parimi V, Ramineni T, Anand P, Shobha V, Shenoy P, Sircar G, Basu k, Das A, Kale G, sarkar i, Goveas S, Sengupta B, Kareem C, Sakthivel Y, Biswas S, Nallulwar N. Prevalence Of Oral Manifestations And Their Association With Clinical And Serological Profile In Systemic Sclerosis Patients- An Indian Study [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/prevalence-of-oral-manifestations-and-their-association-with-clinical-and-serological-profile-in-systemic-sclerosis-patients-an-indian-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-oral-manifestations-and-their-association-with-clinical-and-serological-profile-in-systemic-sclerosis-patients-an-indian-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology